Lawless America

Remicade® & Stevens-Johnson Syndrome (SJS)

January 4, 2021

Administered via injection, Remicade® (generically referred to as infliximab) is a prescription medication used in the treatment of autoimmune diseases, including Crohn's disease, psoriasis and rheumatoid arthritis. Remicade® was initially approved by the U.S. Food and Drug Administration (FDA) in August 1998, and it is produced and distributed by Centocor Ortho Biotech in the U.S. (or Schering-Plough, part of Merck & Co., in other parts of the world).

Despite its ability to reduce inflammation associated with autoimmune diseases, Remicade® is suspected of triggering some serious, life-threatening side effects, in rare cases. Specifically, some people who have taken Remicade® have reported the development infection, lymphoma and Stevens-Johnson syndrome.

Patients with a history of taking Remicade® should contact a defective drug attorney if they are diagnosed with any serious side effect of the drug. Our law firm focuses a lot of our attention on helping people who have suffered Stevens-Johnson syndrome as the result of a drug reaction. We are dedicated to helping people seek compensation for losses such as:

  • medical bills
  • ongoing treatment costs
  • lost wages
  • permanent disabilities
  • emotional pain and suffering

Grieving families who believe their loved ones were killed as a result of a reaction to the medication may also wish to seek compensation for funeral and burial expenses, as well as for all other losses.

Information about Stevens-Johnson Syndrome

Rare but potentially life-threatening, Stevens-Johnson syndrome is a severe skin condition in which the skin's outer layer (epidermis) sheds (sloughs) from the middle layer of skin (dermis) as it dies off. The condition is also marked by fever, diarrhea, vomiting and extreme swelling of the body's mucous membranes (which lie in the eyes, nose, mouth, lower respiratory system and genitals).

If not diagnosed and treated promptly, Stevens-Johnson syndrome may spread to become increasingly life-threatening. When SJS affects more than 30 percent of the body, the condition is referred to as toxic epidermal necrosis syndrome (TENS)—and the prognosis is far more grim for patients.

Long term damage associated with Stevens-Johnson syndrome and toxic epidermal necrolysis include:

  • severe and permanent scarring
  • full or partial vision loss from scarring of the eyes
  • hair loss
  • finger and/or toenail loss
  • organ damage

The worst cases may result in death, as Stevens-Johnson Syndrome patients lose great amounts of salt and liquids with the skin loss caused by the condition.

Lawless America